Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

NCT07075718 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

610

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: Gen 2 Travoprost Intracameral Implant
DRUG: Timolol eye drops 0.5%
PROCEDURE: Sham Procedure
OTHER: Placebo eye drops

Sponsor

Glaukos Corporation